227040
Anti-Cholera Toxin, B-Subunit Goat pAb
lyophilized, Calbiochem®
Sinónimos:
Anti-Cholera Antibody, Cholera Toxin Detection, Goat Anti-Cholera Toxin
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Código UNSPSC:
12352203
NACRES:
NA.43
Productos recomendados
origen biológico
goat
Nivel de calidad
forma del anticuerpo
serum
tipo de anticuerpo
primary antibodies
clon
polyclonal
Formulario
lyophilized
contiene
≤0.1% sodium azide as preservative
fabricante / nombre comercial
Calbiochem®
condiciones de almacenamiento
OK to freeze
isotipo
IgG
Condiciones de envío
ambient
temp. de almacenamiento
2-8°C
modificación del objetivo postraduccional
unmodified
Descripción general
Goat polyclonal antibody supplied as lyophilized undiluted serum. Recognizes cholera toxin B-subunit.
Recognizes the B-subunit of cholera toxin.
This Anti-Cholera Toxin, B-Subunit Goat pAb is validated for use in Immunoblotting, Frozen Sections, Immunocytochemistry, ELISA for the detection of Cholera Toxin, B-Subunit.
Inmunógeno
Vibrio cholerae
non-denatured Cholera Toxin, B-subunit
Aplicación
Immunoblotting (see application references)
Frozen Sections (1:4000; see application references)
Immunocytochemistry (1:200; see application references)
ELISA (1:10,000; see application references)
Frozen Sections (1:4000; see application references)
Immunocytochemistry (1:200; see application references)
ELISA (1:10,000; see application references)
Advertencia
Toxicity: Standard Handling (A)
Forma física
Undiluted serum.
Reconstitución
Reconstitute in 100 µl dH₂O. Further dilute with aqueous buffers, such as PBS.
Otras notas
Antibody should be titrated for optimal results in individual systems.
Vadolas, J., et al. 1995. Eur. J. Immunol. 25, 969.
Craig, J.P. 1971. Microbial Toxins 2A, 189.
Selected Citations
Peters, I., et al. 2009. Biochim. Biophys. Acta1788, 964.
Balasubramanian, N., et al. 2007. Nature Cell Biology9, 1381.
Nemchinov, L.G., Et al. 2000. Arch. Virol.145, 2557.
Craig, J.P. 1971. Microbial Toxins 2A, 189.
Selected Citations
Peters, I., et al. 2009. Biochim. Biophys. Acta1788, 964.
Balasubramanian, N., et al. 2007. Nature Cell Biology9, 1381.
Nemchinov, L.G., Et al. 2000. Arch. Virol.145, 2557.
Información legal
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
¿No encuentra el producto adecuado?
Pruebe nuestro Herramienta de selección de productos.
Código de clase de almacenamiento
11 - Combustible Solids
Clase de riesgo para el agua (WGK)
WGK 1
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Jing Du et al.
Cerebrospinal fluid research, 6, 3-3 (2009-03-19)
It has been shown that distal cerebrospinal fluid-contacting neurons (dCSF-CNs) exist near the ventral midline of the midbrain aqueduct and also in the grey matter of the inferior third ventricle and the fourth ventricle floor in the superior segment of
Jeffrey Hubbard et al.
Proceedings of the National Academy of Sciences of the United States of America, 118(25) (2021-06-23)
Artificial lighting, day-length changes, shift work, and transmeridian travel all lead to sleep-wake disturbances. The nychthemeral sleep-wake cycle (SWc) is known to be controlled by output from the central circadian clock in the suprachiasmatic nuclei (SCN), which is entrained to
Nagaraj Balasubramanian et al.
Nature cell biology, 9(12), 1381-1391 (2007-11-21)
Integrin-mediated adhesion regulates membrane binding sites for Rac1 within lipid rafts. Detachment of cells from the substratum triggers the clearance of rafts from the plasma membrane through caveolin-dependent internalization. The small GTPase Arf6 and microtubules also regulate Rac-dependent cell spreading
L G Nemchinov et al.
Archives of virology, 145(12), 2557-2573 (2001-02-24)
Hepatitis C virus (HCV) is a major cause of acute and chronic hepatitis with over 180 million cases worldwide. Vaccine development for HCV has been difficult. Presently, the virus cannot be grown in tissue culture and there is no vaccine
J Müthing et al.
Glycoconjugate journal, 14(1), 19-28 (1997-01-01)
In this study the comparative TLC immunostaining investigation of neutral GSLs and gangliosides from human skeletal and heart muscle is described. A panel of specific polyclonal and monoclonal antibodies as well as the GM1-specific choleragenoid were used for the overlay
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico